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Introduction
IL-1, IL-6 and TNF-alpha is a typical example of a multi-
functional cytokine that is involved in the immune
response, hemopoiesis and inflammation. In 1999 pub-
lished data on the levels of cytokines in patients with JRA.
It is noted that the level of IL-6 higher in patients with sys-
temic variant of the disease in the active phase. This study
confirms that levels of IL-6 and TNF-alpha can be markers
of disease activity.
Objectives
The aim of our study was to determine the relationship
between the level of cytokines and disease activity among
children with JIA receiving the basic therapy with
methotrexate.
Methods
Determination of the level of IL-1b, IL-6 and TNF-alpha
serum was collected by means of enzyme-linked immu-
nosorbent assay.
Results
We have revealed significantly higher levels of IL-6 in
groups of patients with oligoarticular (52.99±12.03) and
system arthritis (68.76±14.7), compared with the level of
IL-6 in patients with enthesitrelated arthritis (15.53
±4.63) (P<0.05).
When comparing the levels of cytokines in patients
with “Active” and “Inactive” disease depending on the
type of arthritis, identified the following regularities in
patients with systemic JIA in the stage inactive disease,
the level of IL-6 (83.36±26.29) significantly (P<0.05)
higher than these patients with polyarticular (14.65
±6.64) and enthesitrelated arthritis (4.86±1.44). The
level IL-6 significantly higher in patients with systemic
arthritis in “active” phase (61.46±18.39) compared with
the same patients with enthesitrelated JIA (16.86±5.13).
Noteworthy detection of statistically significant higher
level TNFa in patients receiving biological therapy,
mainly TNF inhibitors. Apparently, the continuing high
level of TNF, despite the use of inhibitors, characterizes
this group of patients, as the most severe.
In the group of patients not treated with biological
therapy level TNFa was significantly lower than in the
group of children treated with this type of therapy. The
main biological drugs, which were given to children
with Jia were either direct blockers TNFa (infliximab,
etanercept) or affecting the synthesis of Pro-inflamma-
tory cytokines (tocilizumab, adalimumab).
Conclusion
It was natural to assume that in a group of children
receiving anticytokine drugs the level of TNF-alpha will
be lower. However, in our study we have received signifi-
cantly higher level of TNF-alpha, which indicates a more
severe disease, and on the other hand possible resistance
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